Terumo and Sanofi-Aventis Partner in Vietnam to Boost Interventional Cardiology Expertise

Terumo Vietnam Medical Equipment (Terumo Vietnam) along with Sanofi-Aventis Vietnam have entered into a two-year partnership aimed at enhancing the skills of healthcare providers in the field of interventional cardiology.

Cardiovascular diseases are increasingly prevalent in Vietnam, with acute coronary syndromes (ACS) now being among the top reasons for hospital admissions and fatalities. As reported by the World Health Organization (WHO), these conditions were responsible for almost 70% of non-communicable disease-related deaths in Vietnam up until 2016, underscoring the critical necessity for better treatment protocols and advanced capabilities among primary healthcare providers.

Representatives from Sanofi Aventis Vietnam and Terumo Vietnam at the signing ceremony. The photo was provided by Terumo Vietnam.

Acknowledging this issue, Terumo Vietnam and Sanofi-Aventis Vietnam—two leading players in healthcare dedicated to progressing medical knowledge and enhancing patient care—are joining forces to tackle training deficiencies and foster continuous professional growth among interventional cardiologists across the country. At the heart of their collaboration lies the introduction of the PCI (Percutaneous Coronary Intervention) Roadshow series—a thorough educational program. Over the course of the next 24 months, this series aims to conduct five concentrated workshops spread out through various regions of Vietnam.

Every PCI workshop will include cutting-edge case-based education, practical sessions using sophisticated simulation tools, guided conversations led by experts about approaches to ACS management, as well as the newest knowledge on PCI procedures and advancements in medical devices.

The objective of this program is to keep doctors informed about updated guidelines and best practices, as well as encourage peer-to-peer education and collaborative efforts across different regions within Vietnam’s cardiovascular field.

Nguyen Do Bao Chau, the General Director of Terumo Vietnam, highlighted the significance of doctor education for improving the entire healthcare framework. She stated, "Investing in the growth of medical personnel allows us to support a more robust system capable of promptly and efficiently addressing patient needs." This collaboration underscores their enduring dedication to advancing societal well-being via healthcare improvements.

Representatives from both companies had their picture taken during the ceremony. The photograph was provided courtesy of Terumo Vietnam.

Didier Martin, who leads the pharmaceutical division at Sanofi-Aventis Vietnam, emphasized the importance of strategic partnerships in fostering healthcare innovations. He stated, “Collaboration plays a vital role in promoting innovation and enhancing patient results at Sanofi. In cardiovascular treatment, our company boasts considerable experience. By joining forces with Terumo’s cutting-edge medical technology, we aspire to develop a system that greatly improves the expertise of interventional cardiologists, thus positively impacting patients throughout Vietnam.”

The first workshop, scheduled for mid-2025, has instilled optimism in both firms regarding the initiative’s beneficial effects. This collaboration extends beyond initial educational activities; it paves the way for potential joint ventures in clinical instruction, investigation, and healthcare services.

The two companies discussing about strategic partnership. Photo courtesy of Terumo Vietnam

Based in Tokyo, Terumo stands out as a worldwide pioneer in medical devices, boasting a centennial dedication to "Improving Global Health Through Innovation." Serving more than 160 nations and territories, Terumo delivers cutting-edge offerings including those for vascular procedures and heart surgeries, alongside critical tools like blood transfer systems, diabetic management equipment, and renal therapies. Their portfolio also encompasses everyday essentials used extensively in healthcare settings around the globe.

Sanofi, a pioneering international health care corporation operating across more than 70 nations, has been active in Vietnam for over seven decades. Inspired by their mission to “Pursue scientific breakthroughs to enhance human life,” Sanofi recently outlined a new strategy aimed at solidifying its position as a frontrunner in immunology and becoming the premier biopharmaceutical enterprise driven by large-scale artificial intelligence technology.